AC
PFE icon

ASB Consultores’s Pfizer PFE Stock Holding History

ASB Consultores’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,857
Closed -$341K – 199
2024
Q4 		$341K Buy
12,857
+317
+3% +$8.6K 0.14% 123
2024
Q3 		$363K Sell
12,540
-3,018
-19% -$88K 0.14% 120
2024
Q2 		$435K Sell
15,558
-3,361
-18% -$92.5K 0.16% 87
2024
Q1 		$525K Buy
18,919
+11,659
+161% +$324K 0.14% 112
2023
Q4 		$209K Sell
7,260
-7,088
-49% -$214K 0.07% 105
2023
Q3 		$476K Sell
14,348
-4,161
-22% -$147K 0.19% 49
2023
Q2 		$679K Buy
18,509
+1,273
+7% +$49.5K 0.33% 59
2023
Q1 		$703K Buy
17,236
+5,567
+48% +$240K 0.28% 46
2022
Q4 		$598K Sell
11,669
-919
-7% -$44.1K 0.25% 50
2022
Q3 		$551K Buy
12,588
+1,511
+14% +$73.4K 0.26% 48
2022
Q2 		$581K Buy
11,077
+620
+6% +$31.6K 0.25% 44
2022
Q1 		$541K Buy
10,457
+118
+1% +$6.12K 0.23% 75
2021
Q4 		$611K Buy
+10,339
New +$512K 0.3% 65

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ASB Consultores's PFE Position: Q1 2025 in Review

ASB Consultores sold out of Pfizer (PFE) in Q1 2025, closing a stake of 12,857 shares — an estimated $341K sold.

ASB Consultores first reported a position in PFE in Q4 2021 and held it in 13 quarters. The position peaked at $703K in Q1 2023. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • ASB Consultores reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • ASB Consultores sold 12,857 Pfizer shares in Q1 2025, an estimated $341K.
  • ASB Consultores first reported a position in Pfizer in Q4 2021 and held it in 13 quarters.
  • ASB Consultores's Pfizer position peaked at $703K in Q1 2023.
  • 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on ASB Consultores's 13F filing for Q1 2025, filed 13 May 2025.